OVERVIEW
Caption
Discover how sequencing methods and multi-omics approaches can be used to describe rare diseases from a molecular point of view and contribute to the diagnosis and management of patientsApplication Deadline
2024-10-31CIVIS Hub
Health
Field of studies related to the course
Medicine and Health
General description
Sequencing methods mark a significant advancement in the study of rare diseases. Integrating data from various sources is becoming crucial for enhancing molecular analysis and diagnosis.
The goal of the CIVIS summer school is to offer high-quality, interdisciplinary courses that address these needs.
Main topics addressed during the course
- Fundamental notions in medical genetics
- iPSC to rare diseases
- Biomedical ethics
- R programming
- Sequencing technologies
- Variants analysis
- scRNA-seq
- Spatial transcriptomics
Learning outcomes
The students will improve their knowledge and their skills in rare disease (fundamental notions medical genetics, iPSC to rare diseases, biomedical ethics, etc), cross-cutting skills (R programming, sequencing technologies, variant analysis, scRNA-seq, spatial transcriptomics etc.) and soft skills (English, teamwork, oral presentation, analytical and synthesis skills, build a professional network etc).
PRACTICAL DETAILS
Academic Year
2024/2025
Open to
Master's
PhD candidates/ students
Bachelor's
Hosting university
Aix-Marseille Université
Partner universities
Aix-Marseille Université
University of Bucharest
Paris Londron University of Salzburg
Course language
English
Language level required
B2
Duration of the course (hours)
75 hoursECTS credits
3PHYSICAL MOBILITY
Physical Part starting date
2025-06-23Physical Part closing date
2025-06-27Course location
Marseille, FrancePhysical Part Description
The physical mobility part will be running from 23 to 27 June 2025 in Marseille, France. It will follow on from the virtual part and will alternate between plenary sessions and practical workshops.
- Day 1: Exploring Rare Diseases through Medical Genetics and Genomic Analysis
- Day 2: Single-Cell Insights into Normal and Pathological Development
- Day 3: Mapping the Transcriptome: Unveiling the Power of Spatial Transcriptomics
- Day 4: Unraveling the Role Epigenetics and Gene Regulation in Rare Diseases
- Day 5: iPSC Technologies and their transformative impact on rare disease research – Social event
VIRTUAL COMPONENT
Virtual Part starting date
2025-03-03Virtual Part closing date
2025-04-30Virtual Part Description
The online sessions will take place between 3 March - 30 April 2025. To accommodate your schedule, the courses are offered as self-paced learning modules, complemented by regular online sessions and personalised support from our expert team of instructors.
This part will be about gaining knowledge and fundamentals of R programming by diving into an engaging, interactive learning experience.
ASSESSMENT
Course assessment
The assessment for this programme will consist of:
- Virtual part: multiple-choice questions (MCQ) and dataset analysis.
- Physical part: multiple-choice questions (MCQ).
- active participation in both parts (virtual and physical)
REQUIREMENTS
Academic pre-requisites for applicants
This course is open to Bachelor's, Master's and PhD's students at CIVIS member universities, with knowledge in molecular and cellular biology.
Also, the participants should have:
- excellent English skills (B2),
- data analysis skills,
- medical genetics,
- teamwork spirit,
- oral presentation skills.
Letters of recommendation are welcome.
SELECTION PROCESS
Application requirements
Motivation Letter
CV
Other
Evaluation Criteria
The evaluation will assess the applicant’s background and experience in molecular and cellular biology, including training courses and internships. It will also consider the alignment of the research project and/ or career goals with the summer school’s focus, as well as the applicant’s proficiency in English.
ABOUT THE LECTURERS
About the lecturer(s)
Aix-Marseille Université:
- Denis Puthier, researcher TAGC laboratory, full Professor at the Polytech school of engineering, co-head of the TGML Genomics platform and deputy director for education of the Marseille Rare Disease’s institute
- Thierry Brue, MMG laboratory, Marseille Hospitals, Director of the Marseille Rare Diseases Institute
- Frédérique Magdinier, MMG laboratory (director of the MMG laboratory and deputy director of research of the Marseille Rare Diseases’ institute)
- Aitor Gonzalez, TAGC laboratory, Director of Master degree in Bioinformatics (Marseille)
- Heather Etchevers, MMG laboratory
- Fabienne Lescroart, MMG laboratory
- Sandrine Marquet, TAGC laboratory
University of Salzburg:
- Iris Gratz, Depart. of Biosciences and Medical Biology
- Angelika Lahnsteiner, Depart. of Biosciences and Medical Biology
- Aarathy Geetha, Depart. of Biosciences and Medical Biology
University of Bucharest:
- Beatrice Radu, Faculty of Biology, Department of Anatomy, Animal Physiology and Biophysics
- Bogdan Amuzescu, Dept Biophysics & Physiology, Faculty of Biology